Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals

Autor: Pucca, Manuela Berto, Bertolini, Thais Barboza, Barbosa, Jose Elpidio, Simone Galina, Porto, Geciane Silveira

Publikováno v: Brazilian Journal of Pharmaceutical Sciences, Volume: 47, Issue: 1, Pages: 31-38, Published: MAR 2011
Brazilian Journal of Pharmaceutical Sciences, Vol 47, Iss 1, Pp 31-38 (2011)
ResearcherID
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 No. 1 (2011); 31-38
Brazilian Journal of Pharmaceutical Sciences; Vol. 47 Núm. 1 (2011); 31-38
Brazilian Journal of Pharmaceutical Sciences; v. 47 n. 1 (2011); 31-38
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP

Monoclonal antibodies represent the fastest growing class of biopharmaceutical products and have a host of applications in medical research, diagnosis, therapy, and basic science. The production of recombinant monoclonal antibodies has revolutionized

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::f9e2bd1d93946edcc60af92d3655e655
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502011000100005&lng=en&tlng=en

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.